Trials Sponsors Conditions Drugs Pricing

Conditions

Bronchiectasis Cystic Fibrosis Lung Transplant Progressive Fibrosing Interstitial Lung Disease Pulmonary Tuberculosis

Outcome Measures

Primary Outcomes (1)

Length of time wearing device (days)
Total length of time participant wears device
6 month duration per participant

Secondary Outcomes (2)

Prediction of respiratory exacerbations- Number of emergency room visits
6 month duration per participant
Prediction of respiratory exacerbations- Number of hospital admissions
6 month duration per participant

Study Arms (1)

Device

EXPERIMENTAL

All participants will wear the device to assist in determining the feasibility of wearing the device.

Device: ADAMM- RSM Device

Interventions

ADAMM- RSM DeviceDevice

All participants will wear the ADAMM- RSM device for a 6 month period

Device

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients with PF-ILD (including IPF), lung transplant, CF, bronchiectasis or TB must meet all of the following criteria to be enrolled in the study:
Male or female volunteers, at least 18 years of age at the time of screening visit;

Sponsors & Collaborators

University of Alberta
Otherlead

Study Sites (1)

University of Alberta

Edmonton, Alberta, T6G 2B7, Canada

MeSH Terms

Conditions

Cystic FibrosisBronchiectasisTuberculosis, Pulmonary

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesBronchial DiseasesTuberculosisMycobacterium InfectionsActinomycetales InfectionsGram-Positive Bacterial Infections

Study Officials

Giovanni Ferrara, MD
University of Alberta
PRINCIPAL INVESTIGATOR

Enrollment

8 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: DIAGNOSTIC
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

March 25, 2021

First Posted

April 23, 2021

Study Start

July 1, 2021

Actual (reported)

Primary Completion

Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Device

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Device

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations